RecallDepth
Class II Terminated

Solifenacin Succinate Tablets, 5mg, packaged in a) 30-count bottles (NDC 51991-893-33) and b) 90-count bottles (NDC 51991-893-90) Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487; Manufactured by: Piramal Enterprises Limited Plot No 67-70, Sector -2 Pithampur 454 775, Dist, Dhar Madhya Pradesh, INDIA

This recall has been terminated (originally issued March 25, 2020).

Company
Breckenridge Pharmaceutical, Inc
Recall Initiated
January 24, 2020
Posted
March 25, 2020
Recall Number
D-1050-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,250 bottles
Firm Location
Berlin, CT, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.

Distribution

Product was distributed nationwide within the United States.

Lot / Code Info

Lot #: a) 81244, 81217, Exp. Date 01/2021 and b) 81245, Exp. Date 01/2021

More recalls by Breckenridge Pharmaceutical, Inc

View all recalls by this company →

Other recent Class II Drug recalls